Delve into the Astellas playbook, a strategy relying on "strategic brand" and advancing on "primary focuses" at the same time ...

The companies Aktis Oncology, Alumis, and Parabilis Medicines bagged the biggest biotech funding rounds overall in January ...

Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

Celebrate International Day of Women and Girls in Science 2026 by discovering some of the most influential women shaping biotech today.

Delve into the Amarin v. Hikma case in which the U.S. Supreme Court might settle the skinny label question once and for all.

CRISPR technology offers the promise to cure human genetic diseases with gene editing. This promise became a reality when the world’s first CRISPR therapy was approved by regulators to treat patients ...

Italy’s biotech ecosystem might be slightly smaller and less visible than some other European hubs, but it is home to a growing number of companies advancing ambitious therapeutic programs. From gene ...

The healthcare funding landscape was not particularly kind to the U.K. in 2025. Following Merck pulling out of its $1 billion expansion plans in London, it was evident that life science investments in ...

While non-exhaustive, this list offers an overview of the year’s biotech events taking place around the world, aimed at partnering and connecting with decision makers in biopharma. If there is a ...

Lentiviral vectors are foundational to the success of gene-modified cell therapies, yet their development and manufacture remain complex, costly, and difficult to scale. As cell therapies move toward ...